LYUDMILA KUCHMA: Open Payments
NPI 1194356857 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,948 in 55 payments from 12 companies in 2025. Trend: 2023 $18,375 · 2024 $9,691 · 2025 $11,948
Speaker / faculty: $5,658Travel & lodging: $3,451Food & beverage: $1,789Consulting: $1,050
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 29 | $10,877 |
| Boston Scientific Corporation | 1 | $153 |
| BridgeBio Pharma, Inc. | 3 | $151 |
| AstraZeneca Pharmaceuticals LP | 4 | $148 |
| Novo Nordisk Inc | 2 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $115 |
| Lilly USA, LLC | 1 | $104 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| Amgen Inc. | 1 | $60 |
| PFIZER INC. | 3 | $56 |
Products named: CAMZYOS, WATCHMAN, Attruby, FARXIGA, Wegovy, JARDIANCE, ZEPBOUND, LEQVIO.
Industry payments across NY — which companies pay providers there.
